Hou, H., Sun, D., Liu, K., Jiang, M., Liu, D., Zhu, J., . . . Zhang, X. (2019). The safety and serious adverse events of approved ALK inhibitors in malignancies: A meta-analysis. Cancer Manag Res.
Stile di citazione ChicagoHou, Helei, Dantong Sun, Kewei Liu, Man Jiang, Dong Liu, Jingjuan Zhu, Na Zhou, Jing Cong, e Xiaochun Zhang. "The Safety and Serious Adverse Events of Approved ALK Inhibitors in Malignancies: A Meta-analysis." Cancer Manag Res 2019.
Citazione MLAHou, Helei, et al. "The Safety and Serious Adverse Events of Approved ALK Inhibitors in Malignancies: A Meta-analysis." Cancer Manag Res 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.